They have shown that downregulation of SHLP2 peptide expression was associated with greater PC risk in white men, and high serum SHLP2 concentration accurately ruled out PC in both racial groups, demonstrating potential as a novel diagnostic biomarker for PC [113]. The gene discussed is MT-RNR2; the disease is pachyonychia congenita.